Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
- The purpose of this study is to find out whether combining a short course of
chemotherapy (Fludarabine, Mitoxantrone and Rituximab) followed by Zevalin will be
effective in treating relapsed mantle cell lymphoma.
- The secondary purposes of the study are to determine the safety and to evaluate whether
there is additional benefit from Zevalin therapy following the chemotherapy.